Furthermore, our study shows that chronic treatment with metformin ameliorates brain glucose hypometabolism, improves peripheral glucose intolerance and appears to have a beneficial effect on the overall wellbeing of Tau-VLW mice. The gene discussed is MAPT; the disease is Glucose intolerance.